Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - Solar Enertech Corp. - Exhibit 10.1

EXHIBIT 10.1 

MANAGEMENT AGREEMENT 

THIS AGREEMENT effective as of the 1st day
  of June, 2007 although entered into on April 26, 2007.

	BETWEEN: 	
      SOLAR ENERTECH CORP., a company incorporated under
      the laws of the State of Nevada and having a business address at 1600
      Adams Drive, Menlo Park, CA, 94025 

	. 	
       

	  	
      (the “Company”) 

	  	
       

	AND: 	
      MING-WAI ANTHEA CHUNG, an accountant, having an
        address c/o Solar Enertech Corp. at 1600 Adams Drive, Menlo Park, CA,
        94025 

	  	
       

	  	
      (the “CFO”) 

	A. 	
      The Company is a company incorporated under the laws of
      the State of Nevada;

	 	 
	B. 	
      The Company is in the business of the manufacture,
      distribution and sale of solar energy related products;

	 	 
	C. 	
      The Company requires a person to act as its CFO and, in
      addition to this, provide other management services;

	 	 
	D. 	
      The Company wishes to retain the services of the CFO on
      the terms and conditions of this Agreement;

THIS AGREEMENT WITNESSES that in
consideration of the mutual covenants and agreements hereinafter contained, the
parties agree as follows: 

ARTICLE 1 
APPOINTMENT AND AUTHORITY OF CFO

1.01        APPOINTMENT OF CFO

The Company hereby appoints Ming-Wai Anthea Chung as its CFO to
perform certain services for the benefit of the Company as herein set forth, and
the Company hereby accepts such appointment and authority on the terms and
conditions herein set forth. The CFO further confirms her appointment to the
position of Chief Financial Officer (effected on June 1, 2007) and will hold
said appointment on an interim basis until such time as she may resign or her
appointment is terminated in accordance with the terms herein. 

2

1.02        AUTHORITY OF
CFO 

The CFO shall have no right or authority, express or implied,
to commit or otherwise obligate the Company in any material manner whatsoever
except to the extent specifically provided herein or specifically authorized in
writing by the President of the Company or its Board of Directors. 

1.03        CFO’S
WARRANTIES 

The CFO represents and warrants that she will provide competent
management; that she has the qualifications, experience and capabilities
necessary to carry out the Services to be performed hereunder; and that the
Services will be performed in a competent and efficient manner. 

ARTICLE 2 
CFO’S AGREEMENTS 

2.01       
The CFO will undertake all activities which will further and enhance
the business and affairs of the Company as she is directed by the Company’s
President and its Board of Directors. For purposes of this Agreement, “Company”
means the Company and all of its subsidiaries and affiliates. The CFO
acknowledges that the Company initially has limited personnel and resources, and
that the CFO will be requested to undertake activities which will be outside the
general nature of work ordinarily performed by the CFO of a corporation. 

The CFO, at the expense of and on behalf of the Company, shall:

	 	(a) 	
      make and implement or cause to be implemented all lawful
      decisions of the President of the Company and the Board of Directors of
      the Company (the “Board”) in accordance with and as limited by this
      Agreement; and

	 	 	 
	 	(b) 	
      at all times be subject to the direction of the President
      of the Company and the Board and keep the Board informed as to all
      material matters concerning the CFO’s activities.

2.02        MANAGEMENT
ACTIVITIES 

In carrying out its obligations under this Agreement, the CFO
shall undertake all activities necessary to develop the business of the Company
including those activities described in section 2.01 hereof and including the
following: overseeing, coordinating and supervising the preparation and audit of
the Company's financial statements, overseeing and supervising the preparation
of the Company's financial statement filings in accordance with applicable rules
under the Securities Exchange Act of 1934 and acting as the liaison and contact
person for outside counsel and audit staff on all matters concerning the
preparation, filing and audit of the Company's financial statements
(collectively, the "Services"). 

3

The CFO acknowledges that the Company is a reporting issuer
under the laws of the United States of America and that any funds received as
subscriptions or sales revenues of the Company’s products must be fully
accounted for in a manner in accordance with US GAAP. The CFO agrees that she
will make all reasonably necessary efforts to ensure that the management of the
Company, and the accounting for it, is in accordance with US GAAP principles.

The Services will be delivered and performed primarily in
Shanghai, PRC and at the Company's offices in Shanghai, PRC. 

2.03        AUTHORITY OF
CFO 

The Company hereby authorizes the CFO, subject to the other
provisions of this Agreement, to do all acts and things as the CFO may in her
discretion deem necessary or desirable to enable the CFO to carry out her duties
hereunder, and hereby grants the CFO the inherent authority to undertake all
such activities as a CFO acting as CFO normally has. 

2.04        LIMITATION OF
CFO’S OBLIGATIONS 

Notwithstanding anything in this Agreement, the CFO shall not
be required to expend her own money or to incur any liabilities, obligations,
costs, dues or debts and all money required by the CFO to carry out her duties
under this Agreement shall be provided by the Company to the CFO forthwith upon
the CFO’s request. 

The engagement of the CFO by the Company will be exclusive and
the CFO will devote her full-time energies to acting as CFO of the Company. 

2.05        RELATIONSHIP

The parties confirm the CFO will be a full-time employee of the
Company and will be subject to the control and direction of the President of the
Company and its board of directors; and that income tax deductions and other
deductions will be made by the Company where necessary. 

ARTICLE 3 
COMPANY’S AGREEMENTS 

3.01        COMPENSATION
OF CFO 

As compensation for the services rendered by the CFO pursuant
to this Agreement, the Company agrees to pay the CFO an annual salary of
US$130,000 which amount will be increased to US$150,000 per annum subsequent to
the filing of the first quarterly financial statements which indicate that the
Company has achieved break even which is defined as zero or positive net income
after tax. The annual salary will be further increased to US$175,000 per annum
subsequent to the filing of the first quarterly financial statements which
indicate that the Company has achieved RMB 180 million in sales revenues for the
preceding twelve (12) months 

4

(the "Salary"). The Salary shall be payable on or before the
first day of each month, or if a Saturday, Sunday or holiday, the preceding
business day. 

The Company will reimburse the CFO of reasonable living
expenses such as housing, children’s tuition, transportation, meals and laundry
expenses, etc. Expenses will be reimbursed only when they are supported by
proper receipts. These reimbursable expenses are deducted from monthly salary
and are paid before or together with the next salary payment.

While the Salary is at US$130,000, all Salary in excess of
US$100,000 will be accrued on the Company's books. The accrued amounts will be
payable in cash or shares at the mutual agreement of the Company and the CFO or
immediately payable upon termination of employment. 

The CFO will also be granted that number of incentive stock
options which is agreed to between her and the Company's President. 

The CFO shall be entitled to two weeks paid vacation for every
six months worked under this Agreement with round trip airfare for the CFO and 2
children are paid for by the Company to the destination she chooses. 

3.02        REIMBURSEMENT
OF EXPENSES 

The Company shall only be obligated to pay or reimburse the CFO
for the normal and usual expenses of managing the Company as provided herein,
including, without any limitation, any other expenses as set out herein. In the
event of a dispute between the CFO and the Company regarding the amount set out
in the statement of expenses the Company will nevertheless be obligated to pay
the amount set out herein to the CFO, and the Company may then refer the matter
to arbitration as provided for herein. 

The Company shall be expressly obligated to pay the following
expenses for the CFO: 

(a) Heath Insurance: for the CFO and her immediate family
(spouse and / or children) which health insurance will be effective in China and
which will, at the choice of the CFO, either be reimbursed to her or arranged
for her by the Company (at her direction). The Health Insurance will be under a
plan or policy which is mutually agreed to by the Company's President and the
CFO. 

(b) Vehicle: the Company will provide a car, for the term of
this Agreement, for the CFO, which may be used by her (or directed by her) to
provide transportation to her immediate family (spouse and / or children) and
will also provide a driver 

(c) Relocation Expenses: the Company will reimburse the CFO for
reasonable relocation expenses such as up to four (4) economy air transportation
tickets, shipping fees and temporary housing until she finds suitable housing in
Shanghai. 

3.03        ACCESS TO
COMPANY INFORMATION 

5

The Company shall make available to the CFO such financial
information and data and shall permit the CFO, to have access to such documents
or premises as are reasonably necessary to enable her to perform the Services
provided for under this Agreement. 

3.04        INDEMNITY BY
COMPANY 

The Company agrees to indemnify, defend and hold harmless the
CFO, from and against any and all claims, demands, losses, actions, lawsuits and
other proceedings, judgements and awards, and costs and expenses (including
reasonable legal fees), arising directly, in whole or in part, out of any matter
related to any action taken by the CFO within the scope of her duties or
authority hereunder, excluding only such of the foregoing as arise from the
fraudulent or wilful act or omission of the CFO and the provisions hereof shall
survive termination of this Agreement. Nothing in this paragraph may be
construed to commit the Company to indemnify the CFO or provide insurance where
such an act is prohibited by statutory, legal or regulatory requirements. 

3.05       
DIRECTORS AND OFFICERS INSURANCE 

The Company will obtain Directors and Officers Insurance
(“D&O insurance”) with coverage which is sufficient, in the view of the CFO
and the Company, to insure the CFO against risk. D&O insurance will be in
place for the entire term of the CFO’s employment. This employment agreement is
contingent upon obtaining of D&O insurance. 

ARTICLE 4 
DURATION, TERMINATION AND DEFAULT

4.01        EFFECTIVE
DATE 

This Agreement shall become effective as of the day and year
first above written and shall remain in force, subject to the earlier
termination as provided herein, for a period of two years. Thereafter this
Agreement will continue on a monthly basis, on agreement of the parties hereto,
until terminated in accordance with paragraph 4.02. This Agreement replaces and
supersedes any oral agreement regarding the CFO’s compensation . 

4.02       
TERMINATION 

This Agreement may be terminated by either party at any time
without cause by giving the other party written notice of such termination at
least forty-five (45) days prior to the termination date set forth in such
written notice. 

4.03        DUTIES UPON
TERMINATION 

Upon termination of this Agreement for any reason, the CFO
shall promptly deliver the following in accordance with the directions of the
Company: 

6

	 	(a) 	
      a final accounting, reflecting the balance of expenses
      incurred on behalf of the Company as of the date of termination;

	 	 	 
	 	(b) 	
      all documents pertaining to the Company or this
      Agreement, including but not limited to all books of account, financial
      records, audit working papers, correspondence and contracts, invoices,
      sales records, inventory records and financial data in electronic form
      provided; and

	 	 	 
	 	(c) 	
      all property of the Company, including product inventory,
      which is in her possession or the possession of her family, associates and
      affiliates.

Upon termination, the Company will pay to the CFO any amounts
outstanding to her under this Agreement. 

Upon termination, the Company shall have a security interest
and ownership in any unsold product, inventory or asset of the Company which is
in the possession of the CFO at the time of the termination and the CFO shall be
personally liable for the return of such unsold product, inventory or asset to
the care and control of the Company or for its return to the Company. 

ARTICLE 5 
CONFIDENTIALITY 

5.01        OWNERSHIP OF
WORK PRODUCT 

Subject to section 5.02, all financial data, financial records
(be they in electronic or hard form), reports, documents, concepts, products and
processes together with any marketing schemes, business or sales contracts, or
any business opportunities prepared, produced, developed, or acquired, by or at
the discretion of the CFO alone or in conjunction with other employees of the
Company, directly or indirectly, in connection with or otherwise developed or
first reduced to practice by the CFO performing the services (collectively, the
“Work Product”) shall belong exclusively to the Company which shall be entitled
to all right, interest, profits or benefits in respect thereof and shall further
be entitled to exclusive possession thereof. 

5.02       
CONFIDENTIALITY 

During and for a period of two (2) years after the termination
of this Agreement, the CFO shall not disclose any information, documents, or
Work Product concerning the existing company interests to which the CFO may have
access by virtue of its performance of the services to any person not expressly
authorized by the Company for that purpose.

5.03        RESTRICTIVE
COVENANTS 

The CFO shall, during the term of this Agreement, devote all
reasonable time, attention, and abilities to the business of the Company and,
where directed by the President or the Board, to the 

7

business of companies associated with the Company as is
reasonably necessary for the proper exercise of her duties. 

ARTICLE 6 
MISCELLANEOUS 

6.01        WAIVER;
CONSENTS 

No consent, approval or waiver, express or implied, by either
party to or of any breach or default by the other party in the performance by
the other party of its obligations hereunder shall be deemed or construed to be
a consent or waiver to or of any other breach or default in the performance by
such other party of the same or any other obligations of such other party or to
declare the other party in default, irrespective of how long such failure
continues, shall not constitute a general waiver by such party of its rights
under this Agreement, and the granting of any consent or approval in any one
instance by or on behalf of the Company shall not be construed to waiver or
limit the need for such consent in any other or subsequent instance. 

6.02        GOVERNING LAW

This Agreement shall be governed by the laws of the State of
Nevada and, subject to Section 6.08, any dispute under the terms of this
Agreement shall enure to the courts thereof. 

6.03        NO ASSIGNMENT
PERMITTED 

All of the rights, benefits, duties, liabilities and
obligations of the parties hereto shall enure to the benefit of and be binding
upon the respective successors of the parties provided that in no circumstances
is this Agreement assignable by either party save and except that, where
approved in writing by both parties, the CFO may be assigned to complete tasks
and provide services to a subsidiary of the Company or an associated company
thereof. 

6.04        MODIFICATION
OF AGREEMENT 

Save and except any non-disclosure agreement which may be
executed between the CFO and the Company, this Agreement constitutes the entire
agreement between the CFO and the Company and to be effective any modification
of this Agreement must be in writing and signed by the party to be charged
thereby. 

6.05        NOTICES

All notices, requests and communications required or permitted
hereunder shall be in writing and shall be sufficiently given and deemed to have
been received upon personal delivery or, if mailed, upon the first to occur of
actual receipt of forty-eight (48) hours after being placed in the mail in the
United States, postage prepaid, registered or certified mail, return receipt
requested, respectively addressed to the Company or the CFO as first noted
above, or to such other address as may be specified in writing to the other
party, but notice of a change of address shall be 

8

effective only upon the actual receipt; and provided that in
the event of an interruption in the ordinary postal service, all notices,
requests and communications shall be delivered and not mailed. 

6.06        FURTHER
ASSURANCES 

The parties will execute and deliver all such further documents
and instruments and do all such further acts and things as may be required to
carry out the full intent and meaning of this Agreement and to effect the
transactions contemplated hereby. 

6.07        COUNTERPARTS

This Agreement may be executed in several counterparts, each of
which will be deemed to be an original and all of which will together constitute
one and the same instrument. A faxed signature shall be accepted as an original.

6.08        ARBITRATION

In the event that the parties hereto dispute any matter
concerning the terms and conditions of ther Agreement, the matter will be
determined by a single arbitrator appointed by the parties hereto or, in the
event that the parties are not able to agree on the appointment of a single
arbitrator, either party may request the courts to appoint a single arbitrator
in accordance with commercially normal arbitration practices in the State of
California. The arbitrator shall fix a time and place in San Francisco,
California or, should the parties agree, in Hong Kong, for the purpose of
hearing the evidence and representations of the parties. After hearing any
evidence and representations that the parties may submit, the arbitrator shall
make an award and reduce the same to writing and deliver one copy thereof to
each of the parties. The award shall be kept confidential by the parties hereto
except as disclosure is required by applicable securities laws and regulatory
bodies. The decision of the arbitrator shall be made within 45 days after her or
her appointment subject to any reasonable delay due to unforeseen circumstances.
The parties agree that the award of the single arbitrator shall be final and
binding upon each of them and shall not be subject to appeal. 

6.09        INDEPENDENT
LEGAL ADVICE 

The CFO hereby acknowledges that she has acted for herself
in the preparation and negotiation of this Agreement and acknowledges that she
has been advised to seek independent legal counsel and review of this Agreement,
and in particular tax counsel, prior to its execution. CD Farber Law Corporation
has acted for the Company only in the preparation of this Agreement. The CFO and
the Company acknowledge that CD Farber Law Corporation is not familiar with tax
or employment laws in the PRC and in the United States which might be applicable
to this Agreement, in particular as respects the tax residency of the parties
hereto and any deductions, remittances or withholding which may be required as a
result of the entering into of this Agreement. 

9

IN WITNESS WHEREOF the parties have executed this
Agreement effective June 1, 2007. 

 

SOLAR ENERTECH CORP. 
by its authorized signatory:

      /s/ Leo Shi Young,
President                                   

 

     /s/ Ming-Wai Anthea
Chung                                    
MING-WAI
ANTHEA CHUNGWWW.EXFILE.COM -- 15204 --MATRITECH, INC. -- EXHIBIT 10.1 TO FORM 8-K

    EXHIBIT
      10.1

     

    

      CONTRACT
        AMENDMENT NO. 1

      

      This
        Contract Amendment No. 1
        (“Amendment”) dated June 1, 2007 (“Amendment Date”) by and between Inverness
        Medical Innovations, Inc. with offices at 51 Sawyer Road, Suite 200, Waltham,
        MA
        02453 on behalf of itself and its subsidiaries (“Inverness”) and Matritech,
        Inc., a Delaware corporation with its principal place of business at 330
        Nevada
        Street, Newton, MA 02460 (“Matritech”).

      

      WHEREAS
        Inverness and Matritech are
        parties to a Supply Agreement dated as of November 3, 2006 (the “Agreement”),
        and wish to amend such agreement on the terms and conditions set forth in
        this
        Amendment;

      

      NOW
        THEREFORE the parties agree as
        follows:

      

      1.           Section
        3.2 of the Agreement is amended by adding the sentence: “Each such monthly
        forecast shall be provided to Inverness by the fifth business day of the
        month
        in which such forecast is due to be provided.”

      

      2.           Section
        4.4 of the Agreement is amended and restated as follows:  “Inverness
        shall submit to Matritech for approval a minimum of [ ** ] samples of Product
        from each trial production run.  For the avoidance of doubt, Matritech
        shall pay for such samples in accordance with Section 3
        above.  Approval shall not be unreasonably withheld or delayed by
        Matritech.  Once Matritech has advised Inverness in Writing of its
        approval of the trial production run samples or if Matritech fails to provide
        the Written approval or rejection of the same within 10 Business Days, Inverness
        shall cause the full production run of the Product to be manufactured and
        delivered to Matritech.”

      

      3.           Section
        4.6 of the Agreement is amended by deleting the words “thirty (30) calendar
        months” in the last sentence, and replacing them with the words “[ **
        ], or such longer period as is equal to the shelf life of
        the Product which may be extended in accordance with Section 4.7
        hereof”.

      

      4.           Section
        4.7 of the Agreement is amended and restated as follows:

      

      “The
        Parties agree that upon the Effective Date, the shelf life of the Products
        manufactured by Unotech Diagnostics, Inc. as Approved Custom Manufacturer
        shall
        be [ ** ] and the Specification for the Product manufactured by Unotech
        Diagnostics, Inc. as Approved Custom Manufacturer shall provide for a [ **
        ]
        shelf life.  The shelf life of the Products manufactured by any other
        Approved Custom Manufacturer shall, at the time of commencement of supply
        by
        such Approved Custom Manufacturer, be [ ** ] and the Specification initially
        applicable to Products manufactured by such other Approved Custom Manufacturer
        shall provide for a [ ** ] shelf life.  The Parties agree that the
        shelf life of the Products manufactured by such other Approved Custom
        Manufacturer shall be extended during the term of this Agreement (and the
        corresponding revision of the Specification to a shelf life longer than [
        **
        ] shall be effected) based upon accumulation of
        accelerated and/or real time data related to the Products, by written agreement
        of the Parties, which agreement shall not be unreasonably withheld, conditioned
        or delayed.  In the event that the Parties do not, for any reason,
        agree to extend the shelf life of Products manufactured by such other Approved
        Custom Manufacturer to at least [ ** ] by a date no later than [ ** ] after
        commencement of manufacture by such other Approved Custom Manufacturer, then
        Matritech shall have the right to designate the particular Approved Custom
        Manufacturer for any order rather than merely expressing a preference as
        provided in Section 3.1 hereof.  Commencement of manufacture shall
        mean the manufacture of the first validation pilot of the Product by the
        Approved Custom Manufacturer.”

      

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      5.           Section
        4.12 of the Agreement is amended by adding the following sentences at the
        end of
        the existing provision: “Before manufacture of the Product manufactured by any
        new Approved Custom Manufacturer commences, Matritech, Inverness and the
        new
        Approved Custom Manufacturer shall arrange for a cross function design review
        team made up of personnel of Matritech, Inverness and the new Approved Custom
        Manufacturer to assess whether Technical Information Transfer (as hereinafter
        defined) has taken place.  Inverness’s obligations to supply the
        Product manufactured by a new Approved Custom Manufacturer shall not begin
        until
        Matritech, Inverness and the new Approved Custom Manufacturer have agreed
        in
        writing that Technical Information Transfer has taken place; provided that
        the
        agreement of Inverness and the new Approved Custom Manufacturer that Technical
        Information Transfer has taken place shall not be unreasonably withheld,
        conditioned or delayed.   Promptly after Technical Information
        Transfer or after any Change agreed pursuant to Section 6, Inverness will
        identify to Matritech any specific manufacturing processes necessary for
        the
        manufacture of the Product and different from the manufacturing processes
        used
        by its Approved Custom Manufacturer for the manufacture of similar
        products.  If Inverness, its Approved Custom Manufacturer and
        Matritech agree that such manufacturing processes are different from the
        manufacturing processes used by its Approved Custom Manufacturer for the
        manufacture of similar products and ought reasonably to be excluded from
        Inverness’s indemnification set forth in Section 9.1(b)(such agreement of
        Matritech not to be unreasonably withheld), the parties shall record such
        processes in writing, and such processes will be “Specific Manufacturing
        Processes” for the purposes of Section 9 hereof.  “Technical
        Information Transfer” shall mean the provision to Inverness and the new Approved
        Custom Manufacturer of technical information and explanations relating to
        the
        manufacturing processes used for the Product, for the purpose of assisting
        the
        new Approved Custom Manufacturer to manufacture the Product in accordance
        with
        the Specification.”

      

      6.           Insert
        the following new Section 4.15, and re-number current Section 4.15 as 4.16:
        “Notwithstanding any other provision of this Agreement Inverness shall have
        no
        liability whatsoever under any provision of Section 4, Section 9 or any other
        provision of this Agreement in the event that any of the Products fail to
        conform in all material respects to the Specification at the time of manufacture
        and/or at the time of delivery and/or during the period of the shelf life
        of the
        Product, if such failure to conform results from any failure at any time
        of the
        Matritech Raw Materials and/or such Matritech Raw Materials failing to comply
        to
        the Specification insofar as it relates to them and in particular without
        prejudice to the generality of the foregoing Inverness shall have no liability
        whatsoever in respect of any Product failing to conform to the Specification
        which results from any failure in the reproducibility or the stability of
        any
        gold materials which form part of the Matritech Raw Materials which are utilized
        in the Products.”

       

      
        7.
          Sections 9.1 and 9.2 are deleted in their entirety and replaced with the
          following:

      

      

      “9.1           Inverness
        shall indemnify and hold Matritech harmless from and against any and all
        third
        party suits, actions, losses, obligations, deficiencies, liabilities, claims,
        damages, cost and expense (including court costs and reasonable attorney
        fees)
        (collectively, “Claims”) which arise out of, are caused by, relate to or result
        or occur from or in connection with (a) the failure of any Product manufactured
        by Inverness or an Approved Custom Manufacturer to comply with the warranty
        set
        forth in clause 4.1 above, unless such failure is caused by the Matritech
        Raw
        Materials or (b) a claim that the manufacturing processes of Inverness or
        any
        Approved Custom Manufacturer (except any Specific Manufacturing Process agreed
        pursuant to Section 4.12) infringes or misappropriates the Intellectual Property
        of a Third Party.   For purposes of clarity, a Third Party is a
        party other than Inverness and Matritech.

      

      9.2           Except
        for liability which is contemplated by Section 9.1, Matritech agrees to
        indemnify and hold Inverness and each Approved Custom Manufacturer harmless
        from
        and against any and all Claims which arise out of, are caused by, relate
        to or
        result or occur from or in connection with any and 

       

      
        
           

        

        
          -
            2
            -

          
            

          

        

        
           

        

      

      all
        Products and components thereof, including, without limitation, all Biologicals,
        including without limitation, Claims which arise out of, are caused by, relate
        to or result or occur from or in connection with (a) the use and/or sale
        of the
        Products; (b) any allegation that the Products infringe the Intellectual
        Property Rights of a Third Party (except to the extent that such allegations
        concern a Claim for which Matritech is entitled to indemnification pursuant
        to
        clause 9.1) (c) any failure of the Matritech Raw Materials; and (d) any
        allegation that any Specific Manufacturing Process agreed pursuant to Section
        4.12 infringes the Intellectual Property Rights of a Third Party.”

      

      9.           This
        Amendment is effective as of the date of the original Agreement.

      

      10.           Except
        as expressly set forth in this Amendment, all provisions of the Agreement
        shall
        continue in full force and effect.

      

      In
        witness whereof, the parties have
        executed this Amendment as of the date first above written.

      
 

      
        	
                Inverness
                  Medical Innovations, Inc. 

                 

                
                  By:__________________________

                   

                  Its:__________________________

                   

                  
                     

                    By:__________________________

                     

                    Its:__________________________

                  
 

              	
                Matritech,
                  Inc.

                 

                By:_____________________________

                 

                Its:_____________________________

                 

              

      

    

     

     

    
      
         

      

      
        -
          3
          -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}]]